75552-0
LaboratoryFetal Trisomy 13 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Definition
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
LOINC 6-Axis Classification
Component
Fetal trisomy 13 risk
Property
Imp
Time Aspect
Pt
System
WBC.DNA+Plas.cfDNA
Scale Type
Ord
Method Type
Dosage of chromosome specific cf DNA
Details
Class
MOLPATH.TRISOMY
Order/Observation
Both
Short Name
Fet Ts 13 risk WBC.DNA+cfDNA Ql
Display Name
Trisomy 13 risk Dosage of chromosome-specific cfDNA Ql (Plasma cell-free+WBC DNA) [Interp]
Related Names
Frequently Asked Questions
What is LOINC code 75552-0?
LOINC code 75552-0 identifies "Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative". This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
What does 75552-0 measure?
This code measures Fetal trisomy 13 risk in WBC.DNA+Plas.cfDNA. It belongs to the MOLPATH.TRISOMY class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.